You are here: Industry Insights > cytokine

News List

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research prnasia
November 29, 2021
Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) ...
Techpool UTI Blocks Cytokine Storm & Fights Against COVID-19 cphi-online
June 02, 2021
Cytokine storm is a main cause of worsening and death of COVID-19 patients. Techpool UTI inhibits the release of Inflammatory Cytokines and blocks Cytokine Storm in time to treat COVID-19 patients.
Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing firstwordpharma
May 25, 2021
Brooklyn today announced it has completed a $20M financing to progress the development of the mRNA gene editing and cell therapies technology recently licensed from Factor Biosciences and Novellus Therapeutics.
Researchers identify immune system variation linked to severe COVID-19 cases expresspharma
July 29, 2020
The current study found that one risk factor was the presence of an immune system molecule called alpha interferon-a cytokine mobilised to combat viral pathogens such as the flu virus.
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech pharmafocusasia
March 12, 2019
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer.